Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms

American Journal of Physiology - Cell Physiology

Volumn 305, Issue 8, 2013, Pages

  Cai, Zhiwei ^a   Li, Hongyu ^a   Chen, Jeng Haur ^a,b   Sheppard, David N ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cftr inhibition; Chloride ion channel; Epithelial ion transport; Open channel blockade; Thyroid hormones

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENISTEIN; GLIBENCLAMIDE; LIOTHYRONINE; THYROID HORMONE; VOLTAGE GATED CHLORIDE CHANNEL;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BATH; CHANNEL GATING; CONTROLLED STUDY; ION TRANSPORT; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL;

CFTR INHIBITION; CHLORIDE ION CHANNEL; EPITHELIAL ION TRANSPORT; OPEN-CHANNEL BLOCKADE; THYROID HORMONES;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE; CRICETINAE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENISTEIN; GLYBURIDE; HUMANS; ION CHANNEL GATING; MEMBRANE POTENTIALS; MICE; PATCH-CLAMP TECHNIQUES; THYROXINE; TRIIODOTHYRONINE;

EID: 84885629614     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00052.2013     Document Type: Article

References (71)

1. Ai T, Bompadre SG, Wang X, Hu S, Li M, Hwang TC. Capsaicin potentiates wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride-channel currents. Mol Pharmacol 65: 1415-1426, 2004.
2. Barrett EJ. The thyroid gland. In: Medical Physiology: A Cellular and Molecular Approach, edited by Boron WF, Boulpaep EL. Philadelphia, PA: Saunders/Elsevier, chapt. 49, 2009.
3. Bourke JR, Sand O, Abel KC, Huxham GJ, Manley SW. Chloride channels in the apical membrane of thyroid epithelial cells are regulated by cyclic AMP. J Endocrinol 147: 441-448, 1995.
4. Caci E, Caputo A, Hinzpeter A, Arous N, Fanen P, Sonawane N, Verkman AS, Ravazzolo R, Zegarra-Moran O, Galietta LJV. Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis. Biochem J 413: 135-142, 2008.
5. - channel. J Gen Physiol 122: 605-620, 2003.
6. Cai Z, Sheppard DN. Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity. J Biol Chem 277: 19546-19553, 2002.
7. Champigny G, Verrier B, Gérard C, Mauchamp J, Lazdunski M. Small conductance chloride channels in the apical membrane of thyroid cells. FEBS Lett 259: 263-268, 1990.
8. Chan HC, Ruan YC, He Q, Chen MH, Chen H, Xu WM, Chen WY, Xie C, Zhang XH, Zhou Z. The cystic fibrosis transmembrane conductance regulator in reproductive health and disease. J Physiol 587: 2187-2195, 2009.
9. - channel. J Biol Chem 284: 35495-35506, 2009.
10. Cheng SY, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 31: 139-170, 2010.
11. Cotten JF, Welsh MJ. Cystic fibrosis-associated mutations at arginine 347 alter the pore architecture of CFTR: evidence for disruption of a salt bridge. J Biol Chem 274: 5429-5435, 1999.
12. Cui G, Song B, Turki HW, McCarty NA. Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylureabased blockers. Pflügers Arch 463: 405-418, 2012.
13. Cui G, Zhang ZR, O'Brien ARW, Song B, McCarty NA. Mutations at arginine 352 alter the pore architecture of CFTR. J Membr Biol 222: 91-106, 2008.
14. de Andrade Pinto ACO, Barbosa CML, Ornellas DS, Novaira HJ, de Souza-Menezes J, Ortiga-Carvalho TM, Fong P, Morales MM. Thyroid hormones stimulate renal expression of CFTR. Cell Physiol Biochem 20: 83-90, 2007.
15. De Luca F, Trimarchi F, Sferlazzas C, Benvenga S, Costante G, Mami C, Di Pasquale G, Magazzu G. Thyroid function in children with cystic fibrosis. Eur J Pediatr 138: 327-330, 1982.
16. Dérand R, Bulteau-Pignoux L, Becq F. The cystic fibrosis mutation G551D alters the non-Michaelis-Menten behavior of the cystic fibrosis transmembrane conductance regulator (CFTR) channel and abolishes the inhibitory genistein binding site. J Biol Chem 277: 35999-36004, 2002.
17. Devuyst O, Golstein PE, Sanches MV, Piontek K, Wilson PD, Guggino WB, Dumont JE, Beauwens R. Expression of CFTR in human and bovine thyroid epithelium. Am J Physiol Cell Physiol 272: C1299-C1308, 1997.
18. Farinha CM, Nogueira P, Mendes F, Penque D, Amaral MD. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem J 366: 797-806, 2002.
19. Fong P. Thyroid iodide efflux: a team effort? J Physiol 589: 5929-5939, 2011.
20. Fong P. Time for T. (T3, T4, rT3)? Focus on "Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl_ channel by thyroid hormones involves multiple mechanisms." Am J Physiol Cell Physiol (July 17, 2013). doi:10.1152/ajpcell.00210.2013.
21. Fox JA. Ion channel subconductance states. J Membr Biol 97: 1-8, 1987.
22. Fuller MD, Thompson CH, Zhang ZR, Freeman CS, Schay E, Szakács G, Bakos E, Sarkadi B, McMaster D, French RJ, Pohl J, Kubanek J, McCarty NA. State-dependent inhibition of cystic fibrosis transmembrane conductance regulator chloride channels by a novel peptide toxin. J Biol Chem 282: 37545-37555, 2007.
23. Fuller MD, Zhang ZR, Cui G, McCarty NA. The block of CFTR by scorpion venom is state-dependent. Biophys J 89: 3960-3975, 2005.
24. Gadsby DC, Vergani P, Csanády L. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 440: 477-483, 2006.
25. Gunderson KL, Kopito RR. Conformational states of CFTR associated with channel gating: the role of ATP binding and hydrolysis. Cell 82: 231-239, 1995.
26. Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol Aspects Med 34: 337-349, 2013.
27. Hennager DJ, Ikuma M, Hoshi T, Welsh MJ. A conditional probability analysis of cystic fibrosis transmembrane conductance regulator gating indicates that ATP has multiple effects during the gating cycle. Proc Natl Acad Sci USA 98: 3594-3599, 2001.
28. Holland IB, Cole SPC, Kuchler K, Higgins CF. ABC Proteins: From Bacteria to Man. London: Academic, 2003.
29. Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc 75: 519-631, 2000.
30. Hwang TC, Koeppe RE II, Andersen OS. Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics. Biochemistry 42: 13646-13658, 2003.
31. - channel. Trends Pharmacol Sci 20: 448-453, 1999.
32. Ishihara H, Welsh MJ. Block by MOPS reveals a conformation change in the CFTR pore produced by ATP hydrolysis. Am J Physiol Cell Physiol 273: C1278-C1289, 1997.
33. Jih KY, Hwang TC. Nonequilibrium gating of CFTR on an equilibrium theme. Physiology 27: 351-361, 2012.
34. Jih KY, Sohma Y, Hwang TC. Nonintegral stoichiometry in CFTR gating revealed by a pore-lining mutation. J Gen Physiol 140: 347-359, 2012.
35. Kopeikin Z, Sohma Y, Li M, Hwang TC. On the mechanism of CFTR inhibition by a thiazolidinone derivative. J Gen Physiol 136: 659-671, 2010.
36. Kunzelmann K. CFTR: interacting with everything? News Physiol Sci 16: 167-170, 2001.
37. Lansdell KA, Cai Z, Kidd JF, Sheppard DN. Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl_ channels expressed in murine cell line. J Physiol 524: 317-330, 2000.
38. - channels expressed in Chinese hamster ovary cells. J Physiol 512: 751-764, 1998.
39. Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14: 184-193, 1993.
40. - secretion, and renal cyst growth: a study using CFTR inhibitors. Kidney Int 66: 1926-1938, 2004.
41. -/- pigs suggests mechanisms for hypothyroidism in cystic fibrosis. Exp Physiol 95: 1132-1144, 2010.
42. Li H, Sheppard DN. Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease. BioDrugs 23: 203-216, 2009.
43. Li H, Yang W, Mendes F, Amaral MD, Sheppard DN. Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth. Am J Physiol Renal Physiol 303: F1176-F1186, 2012.
44. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJV, Verkman AS. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 110: 1651-1658, 2002.
45. Marshall J, Fang S, Ostedgaard LS, O'Riordan CR, Ferrara D, Amara JF, Hoppe H IV, Scheule RK, Welsh MJ, Smith AE, Cheng SH. Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. J Biol Chem 269: 2987-2995, 1994.
46. Morales MM, Carroll TP, Morita T, Schwiebert EM, Devuyst O, Wilson PD, Lopes AG, Stanton BA, Dietz HC, Cutting GR, Guggino WB. Both the wild type and a functional isoform of CFTR are expressed in kidney. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1038-F1048, 1996.
47. Okabe N, Fujiwara T, Yamagata Y, Tomita KI. The crystal structure of a major metabolite of thyroid hormone: 3,3=,5=-triiodo-L-thyronine. Biochim Biophys Acta 717: 179-181, 1982.
48. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073, 1989.
49. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 352: 1992-2001, 2005.
50. Schmidt A, Hughes LK, Cai Z, Mendes F, Li H, Sheppard DN, Amaral MD. Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator. Br J Pharmacol 153: 1311-1323, 2008.
51. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79, Suppl 1: S145-S166, 1999.
52. - channel by niflumic acid. Mol Membr Biol 21: 27-38, 2004.
53. - channel. Cell 76: 1091-1098, 1994.
54. Sheppard DN, Robinson KA. Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl_ channels expressed in a murine cell line. J Physiol 503: 333-346, 1997.
55. Sheppard DN, Welsh MJ. Structure and function of the cystic fibrosis transmembrane conductance regulator chloride channel. Physiol Rev 79, Suppl 1: S23-S45, 1999.
56. Aubin CN, Zhou JJ, Linsdell P. Identification of a second blocker binding site at the cytoplasmic mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore. Mol Pharmacol 71: 1360-1368, 2007.
57. Tabcharani JA, Linsdell P, Hanrahan JW. Halide permeation in wildtype and mutant cystic fibrosis transmembrane conductance regulator chloride channels. J Gen Physiol 110: 341-354, 1997.
58. Taddei A, Folli C, Zegarra-Moran O, Fanen P, Verkman AS, Galietta LJV. Altered channel gating mechanism for CFTR inhibition by a highaffinity thiazolidinone blocker. FEBS Lett 558: 52-56, 2004.
59. Tao T, Xie J, Drumm ML, Zhao J, Davis PB, Ma J. Slow conversions among subconductance states of cystic fibrosis transmembrane conductance regulator chloride channel. Biophys J 70: 743-753, 1996.
60. - channels. Biophys J 70: 2696-2703, 1996.
61. Vergani P, Lockless SW, Nairn AC, Gadsby DC. CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433: 876-880, 2005.
62. - channels. J Gen Physiol 121: 17-36, 2003.
63. Verkman AS, Galietta LJV. Chloride channels as drug targets. Nat Rev Drug Discov 8: 153-171, 2009.
64. Visser WE, Friesema ECH, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol Endocrinol 25: 1-14, 2011.
65. Wang F, Zeltwanger S, Yang ICH, Nairn AC, Hwang TC. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating: evidence for two binding sites with opposite effects. J Gen Physiol 111: 477-490, 1998.
66. Welsh MJ, Ramsey BW, Accurso F, Cutting GR. Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill, 2001.
67. - channels: a kinetic analysis of channel regulation. Biophys J 66: 1398-1403, 1994.
68. Woodhull AM. Ionic blockage of sodium channels in nerve. J Gen Physiol 61: 687-708, 1973.
69. Yang B, Sonawane ND, Zhao D, Somlo S, Verkman AS. Smallmolecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J Am Soc Nephrol 19: 1300-1310, 2008.
70. Zegarra-Moran O, Monteverde M, Galietta LJV, Moran O. Functional analysis of mutations in the putative binding site for cystic fibrosis transmembrane conductance regulator potentiators: interaction between activation and inhibition. J Biol Chem 282: 9098-9104, 2007.
71. Zhang ZR, Cui G, Liu X, Song B, Dawson DC, McCarty NA. Determination of the functional unit of the cystic fibrosis transmembrane conductance regulator chloride channel: one polypeptide forms one pore. J Biol Chem 280: 458-468, 2005.